If you have been reading about PT-141 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-12-21. Numbers and descriptions here follow the published literature rather than marketing material.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Cyclic heptapeptide | Synthetic melanocortin analogue |
| Molecular formula | C50H68N14O10 | Corresponds to a mass near 1025 daltons |
| Appearance | White to off-white powder | Lyophilised solid before reconstitution |
| Solubility | Soluble in water and polar solvents | Poor solubility in nonpolar media |
| Common synonyms | Bremelanotide, PT-141 | Code name and international name used interchangeably |
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
Evidence outside the studied population is sparse. Trials have concentrated on premenopausal women with a defined diagnosis, and data for postmenopausal women, men, and people taking interacting medications remain limited. Non-prescription use of the peptide for comparable goals is widespread but is not supported by published controlled data. Observed changes in blood pressure have drawn attention to cardiovascular monitoring during use. The literature generally frames the compound as a targeted receptor agonist rather than a general libido enhancer, and basic questions about mechanism and long-term safety are unresolved.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
== Toxicity == DBNPA exhibits various degrees of toxicity like acute oral toxicity, dermal toxicity and inhalation toxicity while it is stable under normal conditions of use. Contact with strong amines should however be avoided including bases, oxidizing agents and reducing agents. DBNPA is corrosive to mild steel, iron and aluminum. The creation of dust when handling DBNPA should be avoided and precautionary measures against electrostatic discharges should be taken. Avoid heat, open flames and other potential sources of ignition when handling DBNPA. Additionally, DBNPA is corrosive to the eyes. It is moderately toxic by oral or inhalation routes and slightly toxic by the dermal route. DBNPA can kill skin tissue in rabbits when administered at high doses for a prolonged period of time. DBNPA is also a skin sensitizer. In a toxicity study using rats, DBNPA caused breathing difficulty associated with lung or heart disease, as well as weight loss and several deaths at higher doses. When applied to the skin of rats in another study, DBNPA caused changes in body chemistry and dermal irritation at the higher doses. DBNPA is a developmental toxicant in rabbits. It was shown to cause structural alterations (retarded ossification of several fetal skeleton elements) at a maternally non-toxic dose level. DBNPA is not mutagenic. The United States Environmental Protection Agency (EPA) has received several human incident reports in which eye, throat and respiratory irritation, runny nose and headache resulted from spills or misuse of DBNPA.
=== Kurdistan === Hitchens was a longtime observer of Saddam Hussein's regime, and publicly called for his removal, albeit only beginning in 1998. This led him to support the establishment of a self-governing state for the Kurds with political autonomy, if not full independence.
=== Contamination recalls === Considering the animal source of pharmaceutical heparin, the number of potential impurities is relatively large compared with a wholly synthetic therapeutic agent. The range of possible biological contaminants includes viruses, bacterial endotoxins, transmissible spongiform encephalopathy (TSE) agents, lipids, proteins, and DNA. During the preparation of pharmaceutical-grade heparin from animal tissues, impurities such as solvents, heavy metals, and extraneous cations can be introduced. However, the methods employed to minimize the occurrence and to identify and/or eliminate these contaminants are well established and listed in guidelines and pharmacopeias. The major challenge in the analysis of heparin impurities is the detection and identification of structurally related impurities. The most prevalent impurity in heparin is dermatan sulfate (DS), also known as chondroitin sulfate B. The building block of DS is a disaccharide composed of 1,3-linked N-acetyl galactosamine (GalN) and a uronic acid residue, connected via 1,4 linkages to form the polymer. DS is composed of three possible uronic acids (GlcA, IdoA, or IdoA2S) and four possible hexosamine (GalNAc, Gal- NAc4S, GalNAc6S, or GalNAc4S6S) building blocks. The presence of iduronic acid in DS distinguishes it from chondroitin sulfate A and C and likens it to heparin and HS. DS has a lower negative charge density overall compared to heparin.
=== Common names === There are many common names for S. divinorum, including sage of the diviners, ska maría pastora, seer's sage, yerba de la pastora, simply salvia, and colloquially sally-d and magic mint.
Cmin is a term used in pharmacokinetics for the minimum blood plasma concentration reached by a drug during a dosing interval, which is the time interval between administration of two doses. This definition is slightly different from Ctrough, the concentration immediately prior to administration of the next dose. Cmin is the opposite of Cmax, the maximum concentration that the drug reaches. Cmin must be above certain thresholds, such as the minimum inhibitory concentration (MIC), to achieve a therapeutic effect. In most cases Cmin is directly measurable. At steady state the minimum plasma concentration can also be calculated using the following equation:
Sources: en.wikipedia.org
Ion cyclotron resonance is a phenomenon related to the movement of ions in a magnetic field. It is used for accelerating ions in a cyclotron, and for measuring the masses of an ionized analyte in mass spectrometry, particularly with Fourier transform ion cyclotron resonance mass spectrometers. It can also be used to follow the kinetics of chemical reactions in a dilute gas mixture, provided these involve charged species.
According to Mathieu Boisvert, nidana 3-10 correlate with the five skandhas. Boisvert notes that while sañña, "perception", is not found in the twelvefold chain, it does play a role in the processes described by the chain, particularly between feeling and the arising of samskaras. Likewise, Waldron notes that the anusaya, "underlying tendencies, are the link between the cognitive processes of phassa ("contact") and vedana (feeling), and the afflictive responses of tanha ("craving") and upadana ("grasping").
=== Belarus === The 2010 Belarusian protests were mass protest actions in Belarus against the results of the 2010 Belarusian presidential election, which took place on December 19, 2010, and were brutally dispersed. Between 10,000 and 60,000 people took part in the protest on October Square and Independence Square in Minsk. These were followed by the 2011 Belarusian protests. The 2017 Belarusian protests also followed later.
The ASA is closely related to the concept of the solvent-excluded surface (also known as the Connolly's molecular surface area or simply Connolly surface), which is imagined as a cavity in bulk solvent. It is also calculated in practice via a rolling-ball algorithm developed by Frederic Richards and implemented three-dimensionally by Michael Connolly in 1983 and Tim Richmond in 1984. Connolly spent several more years perfecting the method. Implicit solvation Van der Waals surface VADAR tool for analyzing peptide and protein structures Relative accessible surface area
Sources: en.wikipedia.org
== History == In June 2000, the European Commission formally approved the launching of Lantus by Sanofi-Aventis Germany in the European Union. The admission was prolonged on 9 June 2005. A three-fold more concentrated formulation, brand name Toujeo, was introduced after FDA approval in 2015.
OSCE Chairman Alexander Stubb said that he couldn't "make the judgment on who started the war, or how it actually started," and that the OSCE's instruments "are very limited — eight unarmed military observers, compared to the intelligence services of the rest of the world." Journalists were informed by OSCE Deputy Spokeswoman Virginie Coulloudon on "patrol reports" being made "on a daily basis", but Coulloudon also said that "the OSCE is not in a capacity to say who started the war and what happened before the night of [August] 7-8." Journalists documented multiple eyewitnesses' accounts that confirmed the reports that separatist shelling of the Georgian villages in South Ossetia took place before August 7. On 5 August 2008, the tripartite monitoring group, which included Organization for Security and Cooperation in Europe (OSCE) observers and representatives of Russian peacekeepers, issued a report that confirmed attacks against ethnic Georgian villages. The report also stated a 1992 ceasefire agreement was breached by the use of heavy artillery against the Georgian villages located in South Ossetia. The Wall Street Journal (WSJ) wrote that in an interview Grist admitted to crossing through Russian lines without authorization on his own initiative to determine the facts. Due to this fact, he was forced to resign from the OSCE immediately after the war.
== Scientific background == Platelet-derived growth factor (PDGF) is a signalling protein involved in wound healing, tissue repair, and angiogenesis. Research has established that PDGF stimulates chemotaxis and proliferation in monocytes, macrophages and fibroblasts, playing a key regulatory role in the tissue repair cascade. Studies have further shown that exogenous recombinant PDGF-BB significantly accelerates wound closure in both incisional and excisional wound models. Other growth factors, including transforming growth factor-β, have also been studied in experimental wound-healing models. The only PDGF-based drug currently approved by a major regulatory authority is becaplermin, sold under the brand name Regranex, a recombinant human PDGF-BB gel approved by the U.S. Food and Drug Administration (FDA) in 1997 for the treatment of diabetic neuropathic foot ulcers. As of the date of this article, no PDGF drug has been approved for commercial sale in China.
A vacuum (pl.: vacuums or vacua) is space devoid of matter. The word is derived from the Latin adjective vacuus (neuter vacuum) meaning "vacant" or "void". An approximation to such vacuum is a region with a gaseous pressure much less than atmospheric pressure. Physicists often discuss ideal test results that would occur in a perfect vacuum, which they sometimes simply call "vacuum" or free space, and use the term partial vacuum to refer to an actual imperfect vacuum as one might have in a laboratory or in space. In engineering and applied physics on the other hand, vacuum refers to any space in which the pressure is considerably lower than atmospheric pressure. The Latin term in vacuo is used to describe an object that is surrounded by a vacuum. The process in which a mechanical device removes matter from a closed (such as a vacuum chamber) or open (such as a vacuum hose) system in an effort to create a vacuum is called evacuation. Evacuated substances captured, removed from the flowstream in another location, and held under vacuum are sometimes said to be collected by the vacuum system. The mechanical force the atmosphere exerts on air and material obstructing the flow of air into a vacuum is referred to as suction. The quality of a partial vacuum refers to how closely it approaches a perfect vacuum. Other things being equal, lower gas pressure means higher-quality vacuum. For example, a typical vacuum cleaner produces enough suction to reduce air pressure by around 20%. But higher-quality vacuums are possible.
Conservative MP Bob Stewart is found guilty of a racially aggravated public order offence after telling an activist to "go back to Bahrain". BBC News reports that Matthew White, the sixth suspect in the murder of Stephen Lawrence, allegedly confessed to involvement in the killing when he tried to stab a security guard while shoplifting from a supermarket in 2015. Sunak warns that protests planned for Armistice Day on 11 November would be "provocative and disrespectful". 4 November A further allegation of sexual assault is made against Russell Brand, dating from 2010. Home Secretary Suella Braverman announces a plan to deter "those who cause nuisance ... by pitching tents in public spaces" by making it harder for homeless people to access tents, describing it as a "lifestyle choice". Around 100 people are injured after a cruise ship, the Spirit of Discovery, owned by Saga Cruises, is caught in a storm in the Bay of Biscay. 6 November Following a trial at Birmingham Crown Court, Mohammed Abbkr is convicted of attempted murder after he set two elderly worshippers alight after they left mosques in London and Birmingham. The Metropolitan Police urges the organisers of pro-Palestinian marches to delay events planned for Armistice Day. 7 November Charles III attends the 2023 State Opening of Parliament, his first as King. Anastrozole, a drug used for a number of years to treat breast cancer, is licensed for use in England as a preventative option. Prince William announces the five winners of the annual Earthshot Prize.
Sources: en.wikipedia.org
PT-141 is a laboratory code for bremelanotide, a synthetic peptide that activates melanocortin receptors. It has been developed both as an injectable pharmaceutical product and as a research chemical. The two contexts differ sharply in how identity, purity, and dosing are controlled.
It is neither a steroid nor a naturally occurring human hormone. Bremelanotide is a manufactured peptide that mimics part of the melanocortin signalling system by binding receptor proteins. Its effects come from receptor activation, not from replacing a circulating hormone.
The internal lactam bridge locks the peptide into a defined shape, which raises receptor affinity and slows enzymatic breakdown. Linear versions of the same sequence are less stable and bind more weakly. Ring geometry is therefore central to how the molecule behaves in the body.
Cold storage at minus twenty degrees Celsius or below is typical, with desiccant and protection from light. The solid form is far more stable than any solution.